Welcure Drugs & Pharmaceuticals Ltd Q4 Results

  • BSE: 524661
  • NSE: -
  • ISIN: INE331C01025
  • Sector: Biotechnology & Drugs
BSE
0.25-0.01 (-3.85%)
Volume12.47 M
Updated: Wed 22 Jul, 2026 | 15:29:30
NSE
This stock is not traded on NSE
Today: 0.24
0.26
52-Wk: 0.23
1.18

Q4 Results Highlights

  • Total Income
    ₹0.00 Cr.
    -
  • Operating Profit
    ₹-49.86 Cr.
    (3144.07%)
  • Profit After Tax
    ₹-49.86 Cr.
    (NA%)
  • Operating Margin
    NA%
    (NA%)
Note: Comparison is on YoY basis

Quarterly - Welcure Drugs & Pharmaceuticals Ltd Q4 Results

*All figures in crores except per share values
Fiscal PeriodMar 26Dec 25QoQ CompMar 24YoY Comp
Total Operating Expense 49.860.04128408.76%0.083144.07%
Depreciation/ Amortization 0.000.010.00%0.02N/A
Total Revenue 0.000.000.00%-0.030.00%
Operating Income -49.86-0.04128408.76%-0.113144.07%
Net Income -49.861.070.00%-0.020.00%
Selling/ General/ Admin Expenses Total 0.000.020.00%0.010.00%
Other Operating Expenses Total 49.860.01346159.72%0.05459.84%
Net Income Before Taxes -49.861.430.00%-0.020.00%
Diluted Normalized EPS -0.400.130.00%0.000.00%
Recommended For You

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe

      Trending Now In Market